Q-omics provides the consensus-scored MIR381HG profile across patient tissues and cancer cell-line models. MIR381HG expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, MIR381HG RNA expression shows 9,105 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight MESO, and BRCA as cancer lineages where MIR381HG shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.